High levels of Fibroblast Growth Factor-23 (FGF23), renal phosphate wasting, and decreased synthesis of active vitamin D are consequences of mutations in PHEX. The estimated incidence of XLH in Sweden is 5/100,000 live births (2). This evidence concerns the gene FGF23 and X-linked hypophosphatemia.